Endocrinology, Vol 136, 3444-3451, Copyright © 1995 by Endocrine Society

ARTICLES

Effects of somatostatin on cultured human mesangial cells

ML Diez-Marques, C Garcia-Escribano, J Medina, MC Boyano-Adanez, E Arilla, G Torrecilla, D Rodriguez-Puyol and M Rodriguez-Puyol
Department of Physiology, Alcala de Henares University, Madrid, Spain.

The present experiments were devoted to analyzing the hypothesis that somatostatin (SS) could modulate glomerular filtration rate by interacting with mesangial cells. Studies were performed in cultured human mesangial cells, passages 3-5. Radioligand experiments demonstrated the presence in the cells of two kinds of receptors, with high (dissociation constant 14 pM. Number of sites: 426 fmol/mg) and low (dissociation constant 56 pM. Number of sites: 20, 111 fmol/mg) affinity. SS prevented in a dose-dependent manner the reduction in planar cell surface area induced by 100 nM Angiotensin II (AII). This effect was not inhibited by the blockade of the vasorelaxing prostaglandins (indomethacin, 10 microM), nitric oxide (L-N-methyl- arginine, 0.2 mM), adenylate cyclase (2,5'-dideoxyadenosine, 0.1 mM), or guanylate cyclase (Methylene blue, 30 microM; LY-83583, 10 microM), but it was potentiated by zaprinast, an inhibitor of the cyclic GMP (cGMP)-specific phosphodiesterase. SS also blocked the increase in myosin light chain phosphorylation induced by AII. SS increased cGMP synthesis by cultured human mesangial cells, an effect that seemed to be dependent on the stimulation of a particulate guanylate cyclase. Preincubation of the cells with pertussis toxin (0.5 microgram/ml) inhibited the effect of SS on the AII-dependent changes in planar cell surface area, as well as the SS-dependent cGMP stimulation. In summary, these results demonstrate the ability of SS to relax cultured human mesangial cells, thus supporting a role for this peptide in the regulation of the glomerular filtration rate. The SS-dependent mesangial cell relaxation may be due to changes in the intracellular concentrations of cGMP, as a consequence of the activation of a particulate guanylate cyclase.

This article has been cited by other articles:

				S. De Frutos, M. Saura, M. Griera, F. J. Rivero-Vilches, C. Zaragoza, D. Rodriguez-Puyol, and M. Rodriguez-Puyol Differential Regulation of Soluble Guanylyl Cyclase Expression and Signaling by Collagens: Involvement of Integrin-Linked Kinase J. Am. Soc. Nephrol., September 1, 2005; 16(9): 2626 - 2635. [Abstract] [Full Text] [PDF]

				Y. Segev, R. Eshet, I. Rivkis, C. Hayat, L. Kachko, M. Phillip, and D. Landau Comparison between somatostatin analogues and ACE inhibitor in the NOD mouse model of diabetic kidney disease Nephrol. Dial. Transplant., December 1, 2004; 19(12): 3021 - 3028. [Abstract] [Full Text] [PDF]

				D. A. Balster, M. S. O'Dorisio, M. A. Summers, and M. A. Turman Segmental expression of somatostatin receptor subtypes sst1 and sst2 in tubules and glomeruli of human kidney Am J Physiol Renal Physiol, March 1, 2001; 280(3): F457 - F465. [Abstract] [Full Text] [PDF]

				G. Torrecillas, M. d. C. Boyano-Adánez, J. Medina, T. Parra, M. Griera, S. López-Ongil, E. Arilla, M. Rodríguez-Puyol, and D. Rodríguez-Puyol The Role of Hydrogen Peroxide in the Contractile Response to Angiotensin II Mol. Pharmacol., January 1, 2001; 59(1): 104 - 112. [Abstract] [Full Text]

				C. I.-D. L. Cruz, P. Ruiz-Torres, R. G. del Moral, M. Rodriguez-Puyol, and D. Rodriguez-Puyol Age-related progressive renal fibrosis in rats and its prevention with ACE inhibitors and taurine Am J Physiol Renal Physiol, January 1, 2000; 278(1): F122 - F129. [Abstract] [Full Text] [PDF]

				R. J. Bosch, P. Rojo-Linares, G. Torrecillas-Casamayor, M. C. Iglesias-Cruz, D. Rodriguez-Puyol, and M. Rodriguez-Puyol Effects of parathyroid hormone-related protein on human mesangial cells in culture Am J Physiol Endocrinol Metab, December 1, 1999; 277(6): E990 - E995. [Abstract] [Full Text] [PDF]

				V. M. Manzano, M. R. Puyol, D. R. Puyol, and F. J. L. Cazaña Tretinoin Prevents Age-Related Renal Changes and Stimulates Antioxidant Defenses in Cultured Renal Mesangial Cells J. Pharmacol. Exp. Ther., April 1, 1999; 289(1): 123 - 132. [Abstract] [Full Text]